Abstract:The metabolite-rich environment that is the intestinal lumen contains metabolic by-products deriving from microbial fermentation and host cell metabolism, with resident macrophages being constantly exposed to this metabolic flux. Succinate, lactate and itaconate are three metabolites secreted by primed macrophages due to a fragmented tri-carboxylic acid (TCA) cycle. Additionally, succinate and lactate are known by-products of microbial fermentation. How these metabolites impact biological functioning of resident macrophages particularly in response to bacterial infection remains poorly understood. We have investigated the potential influence of these metabolites on macrophage phagocytosis and clearance of Escherichia coli ( E. coli ) infection. Treatment of murine bone-marrow-derived macrophages (BMDMs) with succinate reduced numbers of intracellular E. coli early during infection, while lactate-treated BMDMs displayed no difference throughout the course of infection. Treatment of BMDMs with itaconate lead to higher levels of intracellular E. coli early in the infection with bacterial burden subsequently reduced at later time-points compared to untreated macrophages, indicative of enhanced engulfment and killing capabilities of macrophages in response to itaconate. Expression of engulfment mediators MARCKS, RhoB, and CDC42 were reduced or unchanged following succinate or lactate treatment and increased in itaconate-treated macrophages following E. coli infection. Nitric oxide (NO) levels varied while pro- and anti-inflammatory cytokines differed in secretory levels in all metabolite-treated macrophages post-infection with E. coli or in response to lipopolysaccharide (LPS) stimulation. Finally, the basal phenotypic profile of metabolite-treated macrophages was altered according to marker gene expression, describing how fluid macrophage phenotype can be in response to the microenvironment. Collectively, our data suggests that microbe- and host-derived metabolites can drive distinct macrophage functional phenotypes in response to infection, whereby succinate and itaconate regulate phagocytosis and bactericidal mechanisms, limiting the intracellular bacterial niche and impeding the pathogenesis of infection.

A Role for the Krebs Cycle Intermediate Citrate in Metabolic Reprogramming in Innate Immunity and Inflammation

Metabolic reprogramming in macrophages and dendritic cells in innate immunity

Immunometabolism governs dendritic cell and macrophage function

Intestinal Metabolites Influence Macrophage Phagocytosis and Clearance of Bacterial Infection

Coenzyme A governs proinflammatory macrophage metabolism

Tricarboxylic acid cycle metabolites: new players in macrophage

Metabolic Modulation in Macrophage Effector Function

New Insights on the Role of Lipid Metabolism in the Metabolic Reprogramming of Macrophages

Citrulline Depletion by ASS1 is Required for Proinflammatory Macrophage Activation and Immune Responses

Frontline Science: Monocytes sequentially rewire metabolism and bioenergetics during an acute inflammatory response

The IRE1α-XBP1 Signaling Axis Promotes Glycolytic Reprogramming in Response to Inflammatory Stimuli

Control of immune cell signaling by the immuno-metabolite itaconate

Metabolite itaconate in host immunoregulation and defense

The IRG1-Itaconate axis: A regulatory hub for immunity and metabolism in macrophages

Citrate Serves As a Signal Molecule to Modulate Carbon Metabolism and Iron Homeostasis in Staphylococcus Aureus

Crosstalk between glucose metabolism, lactate production and immune response modulation

Metabolic Messengers: itaconate

Metabolic Reprograming of Microglia in the Regulation of the Innate Inflammatory Response

Itaconate: the poster child of metabolic reprogramming in macrophage function

ACLY Nuclear Translocation in Human Macrophages Drives Proinflammatory Gene Expression by NF-κB Acetylation

Similarities in the Metabolic Reprogramming of Immune System and Endothelium